Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek C Radisky

Showing results (61-70 of 173) with videos related to

Pageof 18
Sort By:
Journal of the National Cancer Institute|March 17, 2022
Lower Exome Sequencing Coverage of Ancestrally African Patients in The Cancer Genome AtlasDaniel P Wickland, Mark E Sherman, Derek C Radisky, et al.
Plos One|November 28, 2012
PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1)Jyotica Batra, Jessica Robinson, Christine Mehner, et al.
The Biochemical Journal|March 10, 2016
Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapyItay Cohen, Olumide Kayode, Alexandra Hockla, et al.
Molecular Biology of the Cell|August 25, 2012
Matrix compliance regulates Rac1b localization, NADPH oxidase assembly, and epithelial-mesenchymal transitionKangAe Lee, Qike K Chen, Cecillia Lui, et al.
Molecular Cancer Research : MCR|December 22, 2012
PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancerAlexandra Hockla, Erin Miller, Moh'd A Salameh, et al.
The Journal of Biological Chemistry|June 18, 2022
Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinomaChristine Mehner, Alexandra Hockla, Mathew Coban, et al.
Molecular Cancer Therapeutics|April 9, 2015
Effective Targeting of Estrogen Receptor-Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101Sahra Borges, Edith A Perez, E Aubrey Thompson, et al.
The Journal of Biological Chemistry|March 20, 2012
Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structureJyotica Batra, Jessica Robinson, Alexei S Soares, et al.
Scientific Reports|February 14, 2019
PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinomaHonghai Ma, Alexandra Hockla, Christine Mehner, et al.
Journal of Cell Science|May 31, 2007
Non-classical export of epimorphin and its adhesion to alphav-integrin in regulation of epithelial morphogenesisYohei Hirai, Celeste M Nelson, Kyoko Yamazaki, et al.
Pageof 18

Showing results (61-70 of 173) with videos related to

Sort By:
Pageof 18
Journal of the National Cancer Institute|March 17, 2022
Lower Exome Sequencing Coverage of Ancestrally African Patients in The Cancer Genome AtlasDaniel P Wickland, Mark E Sherman, Derek C Radisky, et al.
Plos One|November 28, 2012
PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1)Jyotica Batra, Jessica Robinson, Christine Mehner, et al.
The Biochemical Journal|March 10, 2016
Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapyItay Cohen, Olumide Kayode, Alexandra Hockla, et al.
Molecular Biology of the Cell|August 25, 2012
Matrix compliance regulates Rac1b localization, NADPH oxidase assembly, and epithelial-mesenchymal transitionKangAe Lee, Qike K Chen, Cecillia Lui, et al.
Molecular Cancer Research : MCR|December 22, 2012
PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancerAlexandra Hockla, Erin Miller, Moh'd A Salameh, et al.
The Journal of Biological Chemistry|June 18, 2022
Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinomaChristine Mehner, Alexandra Hockla, Mathew Coban, et al.
Molecular Cancer Therapeutics|April 9, 2015
Effective Targeting of Estrogen Receptor-Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101Sahra Borges, Edith A Perez, E Aubrey Thompson, et al.
The Journal of Biological Chemistry|March 20, 2012
Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structureJyotica Batra, Jessica Robinson, Alexei S Soares, et al.
Scientific Reports|February 14, 2019
PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinomaHonghai Ma, Alexandra Hockla, Christine Mehner, et al.
Journal of Cell Science|May 31, 2007
Non-classical export of epimorphin and its adhesion to alphav-integrin in regulation of epithelial morphogenesisYohei Hirai, Celeste M Nelson, Kyoko Yamazaki, et al.
Pageof 18